MRO has announced the acquisition of Clinetic, a recruitment management platform that leverages artificial intelligence and real-time Electronic Health Record (EHR) data to identify and enroll clinical trial participants with greater efficiency and accuracy. Financial terms of the deal have not been disclosed.
The acquisition reinforces MRO’s commitment to serving as a single source for smarter healthcare data. Through this integration, MRO aims to improve data accessibility and streamline clinical trial workflows for healthcare providers and life sciences organizations.
Clinetic’s software connects directly to provider EHR systems through secure, behind-the-firewall connectors, enabling direct access to both historical and live patient data. This infrastructure supports rapid and precise patient screening, addressing longstanding challenges related to time and resource constraints in trial recruitment. By utilizing real-time data layers, research teams can:
Identify eligible patients more efficiently across diverse therapeutic areas.
Build more refined and targeted patient cohorts.
Design and execute clinical studies with increased confidence and accuracy.
Clinetic’s technology is already integrated across a broad network, analyzing data from over 15 million patients nationwide. Its combination of data science and healthcare expertise provides a foundation for expanding the scalability of clinical research.
Tom Kaminski, CEO of Clinetic, stated, “Clinetic has strong roots in healthcare, already evaluating the data of more than 15 million patients across the US. Joining MRO was a natural fit, considering our joint focus on transforming unstructured clinical data into actionable data sets and unwavering commitment to our hospital partners and the communities they serve.”
The collaboration positions MRO to enhance its role in supporting healthcare organizations seeking to modernize data management and accelerate research outcomes through AI-enabled, patient-centric technologies. The integration of Clinetic’s recruitment platform is expected to further improve clinical trial efficiency while upholding strict data privacy and security standards.
Click here for the original news story.